The international independent ranking organisation AD Scientific Index is more than an ordinary "Ranking". The "AD Scientific Index" analyses the academic work of scientists using the H-index, i10 index and number of citations, and provides results that can be used to evaluate the productivity and efficiency of individuals and institutions. In addition to ranking according to "total H-index" for individuals and institutions, you can also see the ranking and analyses according to "last 6 years H-index", "total i10 Productivity index", "last 6 years i10 Productivity index", "total citations" and "last 6 years citations" only in "AD Scientific Index". See also: Subject Rankings, University Subject Rankings and  Universities Rankings 2024 (Sort by: Last 6 years H Index).   Click here for individual or institutional registration.

Total 54 scientist
Richard I Fisher
Lymphoma
Blood Cell Development and Function
H-Index Rankings
University / Institution:
# 1
Country:
# 1,858
Region:
# 1,999
World:
# 3,992
H-Index
Total:
122
Last 6 Year:
62
Last 6 Year/Total:
0.508
i10 Index
Total:
391
Last 6 Year:
158
Last 6 Year/Total:
0.404
Citation
Total:
99,696
Last 6 Year:
30,682
Last 6 Year/Total:
0.308
H-Index Rankings
University / Institution:
# 2
Country:
# 2,620
Region:
# 2,825
World:
# 5,631
H-Index
Total:
112
Last 6 Year:
43
Last 6 Year/Total:
0.384
i10 Index
Total:
353
Last 6 Year:
175
Last 6 Year/Total:
0.496
Citation
Total:
51,641
Last 6 Year:
11,181
Last 6 Year/Total:
0.217
H-Index Rankings
University / Institution:
# 3
Country:
# 6,798
Region:
# 7,427
World:
# 15,108
H-Index
Total:
86
Last 6 Year:
34
Last 6 Year/Total:
0.395
i10 Index
Total:
296
Last 6 Year:
95
Last 6 Year/Total:
0.321
Citation
Total:
30,178
Last 6 Year:
4,565
Last 6 Year/Total:
0.151
Erica Golemis
Cancer
Targeted therapy
Signal Transduction
Polycystic Kidney Disease
H-Index Rankings
University / Institution:
# 5
Country:
# 8,285
Region:
# 9,069
World:
# 18,642
H-Index
Total:
81
Last 6 Year:
39
Last 6 Year/Total:
0.481
i10 Index
Total:
192
Last 6 Year:
127
Last 6 Year/Total:
0.661
Citation
Total:
21,871
Last 6 Year:
6,166
Last 6 Year/Total:
0.282
H-Index Rankings
University / Institution:
# 7
Country:
# 12,664
Region:
# 13,997
World:
# 29,847
H-Index
Total:
70
Last 6 Year:
42
Last 6 Year/Total:
0.600
i10 Index
Total:
173
Last 6 Year:
112
Last 6 Year/Total:
0.647
Citation
Total:
30,403
Last 6 Year:
13,465
Last 6 Year/Total:
0.443
Edna (Eti) Cukierman
Tumor microenvironment
cancer associated fibroblasts
extracellular matrix
pancreatic cancer
integrins
H-Index Rankings
University / Institution:
# 14
Country:
# 26,925
Region:
# 30,169
World:
# 70,196
H-Index
Total:
52
Last 6 Year:
36
Last 6 Year/Total:
0.692
i10 Index
Total:
83
Last 6 Year:
62
Last 6 Year/Total:
0.747
Citation
Total:
19,425
Last 6 Year:
8,049
Last 6 Year/Total:
0.414
J Robert Beck
Clinical Decision Making
Comparative Effectiveness
H-Index Rankings
University / Institution:
# 16
Country:
# 31,456
Region:
# 35,355
World:
# 84,229
H-Index
Total:
49
Last 6 Year:
21
Last 6 Year/Total:
0.429
i10 Index
Total:
127
Last 6 Year:
36
Last 6 Year/Total:
0.283
Citation
Total:
14,540
Last 6 Year:
2,913
Last 6 Year/Total:
0.200
H-Index Rankings
University / Institution:
# 18
Country:
# 35,944
Region:
# 40,443
World:
# 98,567
H-Index
Total:
46
Last 6 Year:
20
Last 6 Year/Total:
0.435
i10 Index
Total:
64
Last 6 Year:
29
Last 6 Year/Total:
0.453
Citation
Total:
12,287
Last 6 Year:
2,500
Last 6 Year/Total:
0.203
Crystal Denlinger
oncology drug development
gastroesophageal cancer
hepatobiliary cancers
gastrointestinal oncology
cancer survivorship
H-Index Rankings
University / Institution:
# 19
Country:
# 36,186
Region:
# 40,710
World:
# 99,332
H-Index
Total:
45
Last 6 Year:
39
Last 6 Year/Total:
0.867
i10 Index
Total:
102
Last 6 Year:
87
Last 6 Year/Total:
0.853
Citation
Total:
11,139
Last 6 Year:
8,499
Last 6 Year/Total:
0.763
Anthony Olszanski
Phase 1 drug development
Melanoma
Lung cancer
H-Index Rankings
University / Institution:
# 21
Country:
# 43,671
Region:
# 49,248
World:
# 124,244
H-Index
Total:
41
Last 6 Year:
32
Last 6 Year/Total:
0.780
i10 Index
Total:
90
Last 6 Year:
74
Last 6 Year/Total:
0.822
Citation
Total:
8,133
Last 6 Year:
5,796
Last 6 Year/Total:
0.713
Jeffrey Farma
Cancer
surgical oncology
melanoma
colorectal cancer
sarcoma
H-Index Rankings
University / Institution:
# 25
Country:
# 50,108
Region:
# 56,614
World:
# 146,543
H-Index
Total:
38
Last 6 Year:
31
Last 6 Year/Total:
0.816
i10 Index
Total:
73
Last 6 Year:
67
Last 6 Year/Total:
0.918
Citation
Total:
8,956
Last 6 Year:
7,121
Last 6 Year/Total:
0.795
H-Index Rankings
University / Institution:
# 27
Country:
# 51,270
Region:
# 57,941
World:
# 150,946
H-Index
Total:
38
Last 6 Year:
22
Last 6 Year/Total:
0.579
i10 Index
Total:
82
Last 6 Year:
58
Last 6 Year/Total:
0.707
Citation
Total:
5,945
Last 6 Year:
2,394
Last 6 Year/Total:
0.403
H-Index Rankings
University / Institution:
# 29
Country:
# 54,279
Region:
# 61,360
World:
# 161,396
H-Index
Total:
37
Last 6 Year:
16
Last 6 Year/Total:
0.432
i10 Index
Total:
67
Last 6 Year:
24
Last 6 Year/Total:
0.358
Citation
Total:
5,715
Last 6 Year:
841
Last 6 Year/Total:
0.147
John Karanicolas
Designing small-molecule modulators of protein activity using computational and biochemical approaches
H-Index Rankings
University / Institution:
# 30
Country:
# 55,681
Region:
# 62,934
World:
# 166,451
H-Index
Total:
36
Last 6 Year:
26
Last 6 Year/Total:
0.722
i10 Index
Total:
57
Last 6 Year:
48
Last 6 Year/Total:
0.842
Citation
Total:
8,897
Last 6 Year:
4,554
Last 6 Year/Total:
0.512
Jennifer B Reese
Cancer survivorship
sexual function
behavioral interventions
H-Index Rankings
University / Institution:
# 32
Country:
# 60,496
Region:
# 68,452
World:
# 183,831
H-Index
Total:
34
Last 6 Year:
29
Last 6 Year/Total:
0.853
i10 Index
Total:
58
Last 6 Year:
53
Last 6 Year/Total:
0.914
Citation
Total:
4,215
Last 6 Year:
2,743
Last 6 Year/Total:
0.651
Tetyana Bagnyukova
targeted therapy
immunotherapy
animal models for preclinical evaluation of anticancer drugs
H-Index Rankings
University / Institution:
# 37
Country:
# 79,886
Region:
# 90,443
World:
# 256,164
H-Index
Total:
29
Last 6 Year:
19
Last 6 Year/Total:
0.655
i10 Index
Total:
34
Last 6 Year:
25
Last 6 Year/Total:
0.735
Citation
Total:
4,128
Last 6 Year:
1,332
Last 6 Year/Total:
0.323
H-Index Rankings
University / Institution:
# 40
Country:
# 88,830
Region:
# 100,580
World:
# 291,101
H-Index
Total:
27
Last 6 Year:
17
Last 6 Year/Total:
0.630
i10 Index
Total:
31
Last 6 Year:
25
Last 6 Year/Total:
0.806
Citation
Total:
2,345
Last 6 Year:
837
Last 6 Year/Total:
0.357
H-Index Rankings
University / Institution:
# 41
Country:
# 91,733
Region:
# 103,833
World:
# 302,041
H-Index
Total:
26
Last 6 Year:
21
Last 6 Year/Total:
0.808
i10 Index
Total:
49
Last 6 Year:
39
Last 6 Year/Total:
0.796
Citation
Total:
3,908
Last 6 Year:
2,359
Last 6 Year/Total:
0.604
H-Index Rankings
University / Institution:
# 42
Country:
# 92,272
Region:
# 104,450
World:
# 304,269
H-Index
Total:
26
Last 6 Year:
20
Last 6 Year/Total:
0.769
i10 Index
Total:
43
Last 6 Year:
31
Last 6 Year/Total:
0.721
Citation
Total:
3,711
Last 6 Year:
1,532
Last 6 Year/Total:
0.413
H-Index Rankings
University / Institution:
# 43
Country:
# 98,851
Region:
# 111,917
World:
# 330,509
H-Index
Total:
25
Last 6 Year:
16
Last 6 Year/Total:
0.640
i10 Index
Total:
39
Last 6 Year:
22
Last 6 Year/Total:
0.564
Citation
Total:
3,389
Last 6 Year:
1,482
Last 6 Year/Total:
0.437
Mohan Doss
low dose radiation
cancer
PET imaging
Biodistribution and Dosimetry
radiation hormesis
H-Index Rankings
University / Institution:
# 45
Country:
# 104,247
Region:
# 117,986
World:
# 351,567
H-Index
Total:
24
Last 6 Year:
16
Last 6 Year/Total:
0.667
i10 Index
Total:
43
Last 6 Year:
24
Last 6 Year/Total:
0.558
Citation
Total:
2,155
Last 6 Year:
749
Last 6 Year/Total:
0.348
H-Index Rankings
University / Institution:
# 46
Country:
# 104,743
Region:
# 118,545
World:
# 353,490
H-Index
Total:
24
Last 6 Year:
15
Last 6 Year/Total:
0.625
i10 Index
Total:
39
Last 6 Year:
21
Last 6 Year/Total:
0.538
Citation
Total:
1,976
Last 6 Year:
683
Last 6 Year/Total:
0.346
H-Index Rankings
University / Institution:
# 52
Country:
# 125,138
Region:
# 141,425
World:
# 433,667
H-Index
Total:
21
Last 6 Year:
13
Last 6 Year/Total:
0.619
i10 Index
Total:
23
Last 6 Year:
18
Last 6 Year/Total:
0.783
Citation
Total:
1,678
Last 6 Year:
499
Last 6 Year/Total:
0.297
Michael Bartel
Pancreatitis
Endoscopic ultrasound
Enteroscopy
Endoscopic mucosal resection
H-Index Rankings
University / Institution:
# 53
Country:
# 127,167
Region:
# 143,666
World:
# 441,394
H-Index
Total:
20
Last 6 Year:
19
Last 6 Year/Total:
0.950
i10 Index
Total:
30
Last 6 Year:
23
Last 6 Year/Total:
0.767
Citation
Total:
1,454
Last 6 Year:
961
Last 6 Year/Total:
0.661
Anna Nikonova
ADPKD
primary cilium
cancer biology
lung cancer
head and neck cancer
H-Index Rankings
University / Institution:
# 54
Country:
# 128,101
Region:
# 144,712
World:
# 444,991
H-Index
Total:
20
Last 6 Year:
18
Last 6 Year/Total:
0.900
i10 Index
Total:
30
Last 6 Year:
25
Last 6 Year/Total:
0.833
Citation
Total:
2,063
Last 6 Year:
1,346
Last 6 Year/Total:
0.652
AD Scientific Index - World Scientists Rankings - 2024 H INDEX i10 INDEX CITATION
University /
Institution
Country Region World Name Country University / Institution Subject Total Last 6 year Last 6 year/total Total Last 6 year Last 6 year/total Total Last 6 year Last 6 year/total
1 1,858 1,999 3,992
United States United States Fox Chase Cancer Center Fox Chase Cancer Center Others

Lymphoma | Blood Cell Development and Function |

122 62 0.508 391 158 0.404 99,696 30,682 0.308
2 2,620 2,825 5,631
United States United States Fox Chase Cancer Center Fox Chase Cancer Center Others

cancer research |

112 43 0.384 353 175 0.496 51,641 11,181 0.217
3 6,798 7,427 15,108
United States United States Fox Chase Cancer Center Fox Chase Cancer Center Others

Breast cancer |

86 34 0.395 296 95 0.321 30,178 4,565 0.151
5 8,285 9,069 18,642
United States United States Fox Chase Cancer Center Fox Chase Cancer Center Others

Cancer | Targeted therapy | Signal Transduction | Polycystic Kidney Disease |

81 39 0.481 192 127 0.661 21,871 6,166 0.282
7 12,664 13,997 29,847
United States United States Fox Chase Cancer Center Fox Chase Cancer Center Others

cancer |

70 42 0.600 173 112 0.647 30,403 13,465 0.443
14 26,925 30,169 70,196
United States United States Fox Chase Cancer Center Fox Chase Cancer Center Others

Tumor microenvironment | cancer associated fibroblasts | extracellular matrix | pancreatic cancer | integrins |

52 36 0.692 83 62 0.747 19,425 8,049 0.414
16 31,456 35,355 84,229
United States United States Fox Chase Cancer Center Fox Chase Cancer Center Others

Clinical Decision Making | Comparative Effectiveness |

49 21 0.429 127 36 0.283 14,540 2,913 0.200
18 35,944 40,443 98,567
United States United States Fox Chase Cancer Center Fox Chase Cancer Center Others

virology | hepatitis |

46 20 0.435 64 29 0.453 12,287 2,500 0.203
19 36,186 40,710 99,332
United States United States Fox Chase Cancer Center Fox Chase Cancer Center Others

oncology drug development | gastroesophageal cancer | hepatobiliary cancers | gastrointestinal oncology | cancer survivorship |

45 39 0.867 102 87 0.853 11,139 8,499 0.763
21 43,671 49,248 124,244
United States United States Fox Chase Cancer Center Fox Chase Cancer Center Others

Phase 1 drug development | Melanoma | Lung cancer |

41 32 0.780 90 74 0.822 8,133 5,796 0.713
Adscientificindex

Click for INSTITUTIONAL BULK REGISTRATION and PREMIUM MEMBERSHIP advantages

Adscientificindex
25 50,108 56,614 146,543
United States United States Fox Chase Cancer Center Fox Chase Cancer Center Others

Cancer | surgical oncology | melanoma | colorectal cancer | sarcoma |

38 31 0.816 73 67 0.918 8,956 7,121 0.795
27 51,270 57,941 150,946
United States United States Fox Chase Cancer Center Fox Chase Cancer Center Others

[email protected] |

38 22 0.579 82 58 0.707 5,945 2,394 0.403
29 54,279 61,360 161,396
United States United States Fox Chase Cancer Center Fox Chase Cancer Center Others

cancer | mutation detection |

37 16 0.432 67 24 0.358 5,715 841 0.147
30 55,681 62,934 166,451
United States United States Fox Chase Cancer Center Fox Chase Cancer Center Others

Designing small-molecule modulators of protein activity using computational and biochemical approaches |

36 26 0.722 57 48 0.842 8,897 4,554 0.512
32 60,496 68,452 183,831
United States United States Fox Chase Cancer Center Fox Chase Cancer Center Others

Cancer survivorship | sexual function | behavioral interventions |

34 29 0.853 58 53 0.914 4,215 2,743 0.651
37 79,886 90,443 256,164
United States United States Fox Chase Cancer Center Fox Chase Cancer Center Others

targeted therapy | immunotherapy | animal models for preclinical evaluation of anticancer drugs |

29 19 0.655 34 25 0.735 4,128 1,332 0.323
40 88,830 100,580 291,101
United States United States Fox Chase Cancer Center Fox Chase Cancer Center Others

27 17 0.630 31 25 0.806 2,345 837 0.357
41 91,733 103,833 302,041
United States United States Fox Chase Cancer Center Fox Chase Cancer Center Others

Cancer |

26 21 0.808 49 39 0.796 3,908 2,359 0.604
42 92,272 104,450 304,269
United States United States Fox Chase Cancer Center Fox Chase Cancer Center Others

cancer |

26 20 0.769 43 31 0.721 3,711 1,532 0.413
43 98,851 111,917 330,509
United States United States Fox Chase Cancer Center Fox Chase Cancer Center Others

25 16 0.640 39 22 0.564 3,389 1,482 0.437
45 104,247 117,986 351,567
United States United States Fox Chase Cancer Center Fox Chase Cancer Center Others

low dose radiation | cancer | PET imaging | Biodistribution and Dosimetry | radiation hormesis |

24 16 0.667 43 24 0.558 2,155 749 0.348
46 104,743 118,545 353,490
United States United States Fox Chase Cancer Center Fox Chase Cancer Center Others

preclinical imaging | cancer |

24 15 0.625 39 21 0.538 1,976 683 0.346
52 125,138 141,425 433,667
United States United States Fox Chase Cancer Center Fox Chase Cancer Center Others

GIST | sarcoma |

21 13 0.619 23 18 0.783 1,678 499 0.297
53 127,167 143,666 441,394
United States United States Fox Chase Cancer Center Fox Chase Cancer Center Others

Pancreatitis | Endoscopic ultrasound | Enteroscopy | Endoscopic mucosal resection |

20 19 0.950 30 23 0.767 1,454 961 0.661
54 128,101 144,712 444,991
United States United States Fox Chase Cancer Center Fox Chase Cancer Center Others

ADPKD | primary cilium | cancer biology | lung cancer | head and neck cancer |

20 18 0.900 30 25 0.833 2,063 1,346 0.652